ArticleCritical care (London, England)2011

Treatment effects of recombinant human soluble thrombomodulin in patients with severe sepsis: a historical control study.

Kazuma Yamakawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.